中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/34958
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 29490/55136 (53%)
造訪人次 : 1498176      線上人數 : 186
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於CMUR ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/34958


    題名: An Open-Label, Multicentre Study of Levocetirizine for the Treatment of Allergic Rhinitis and Urticaria in Taiwanese Patients
    作者: (Sheen-Yie Fang);(Diahn-Warng Perng);(J. Yu-Yun Lee);(Ding-Yu Lin)*;黃志揚(Chih-Yang Huang)*
    貢獻者: 基礎醫學研究所
    關鍵詞: allergic rhinitis;urticaria;levocetirizine;patient perception;persistent allergic rhinitis
    日期: 2010
    上傳時間: 2010-11-19 17:09:53 (UTC+8)
    摘要: Levocetirizine has been shown in observational studies in the west as an effective and
    satisfactory therapy for patients with allergic respiratory and skin disease. An open-label,
    multicentre observational study to investigate the patients’ perception of levocetirizine in the
    treatment of allergic rhinitis (AR) and urticaria in Taiwanese patients. Three hundred and
    thirty-three patients (236 AR and 97 urticaria patients) attending out-patient clinics of
    medical centres across Taiwan. Patients were treated with levocetirizine 5mg once daily (AR
    patients for 2-4 weeks and urticaria patients for 2-6 weeks) and at the end of treatment
    evaluated for symptoms of disease, perception of change in symptoms, global efficacy and
    tolerability, global preference over previous antiallergic treatment, change in quality of
    sleep/daily activities, and safety and adverse events (AEs). Levocetirizine markedly improved
    the symptoms of AR and urticaria; with 70%-75% of AR patients and 60%-80% of urticaria
    patients reporting complete or marked improvements in individual symptoms. Asthma
    symptoms were completely or markedly improved in 44% of patients with AR and
    concomitant asthma. The majority of patients were satisfied with levocetirizine therapy and
    50%-70% indicated preference for levocetirizine over previous therapy. Overall, 50%-74% of
    all patients perceived improvements in quality of sleep/daily activities and 50%-65% of the
    patients rated the onset of action for levocetirizine as very rapid or rapid. Somnolence was the
    most common AE, reported by 7.4% of AR and 7.0% of urticaria patients. The results of this
    study indicated Levocetirizine is an effective and satisfactory therapy for the management of
    allergic respiratory and skin disease in Taiwanese subjects.
    關聯: CHINESE JOURNAL OF PHYSIOLOGY 53(4):199-207
    顯示於類別:[基礎醫學研究所] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    20101025094509.pdf186KbAdobe PDF678檢視/開啟


    在CMUR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

     

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋